Finanzdaten der Standard Biotools Inc-Aktie (LAB)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 3.58%19.39 | 20.10 | 21.15 | 23.80 | 19.55 |
| Cost Of Revenue | 10.58%8.56 | 9.57 | 9.84 | 12.41 | 10.07 |
| Gross Profit | 2.78%10.83 | 10.54 | 11.31 | 11.38 | 9.48 |
14.83%30.60 | 35.92 | 23.80 | 36.03 | 42.42 | |
| Selling, General, and Administrative | 2.78%16.84 | 16.39 | 18.61 | 25.34 | 26.60 |
| Research and Development | 5.16%2.08 | 1.98 | 2.12 | 7.97 | 6.36 |
| Operating Income/Loss | 22.14%-19.77 | -25.39 | -12.50 | -24.64 | -32.94 |
| Income/Loss From Continuing Operations Before Tax | 30.25%-14.95 | -21.44 | -14.62 | -22.03 | -32.90 |
| Income Tax Expense/Benefit | 70.00%0.03 | 0.09 | 0.01 | -35.93 | -1.22 |
| Income/Loss From Continuing Operations After Tax | 30.42%-14.98 | -21.53 | -14.63 | 13.90 | -31.68 |
| Income/Loss From Discontinued Operations, Net Of Tax | 643.86%28.46 | -5.23 | 141.69 | 5.38 | -3.00 |
150.39%13.48 | -26.76 | 127.07 | 19.28 | -34.69 | |
| Attributable To Parent | 150.39%13.48 | -26.76 | 127.07 | 19.28 | -34.69 |
| Basic Average Shares | 0.68%393.56 | 390.88 | 388.20 | - | 382.63 |
| Diluted Average Shares | 0.68%393.56 | 390.88 | 388.20 | - | 382.63 |
| Basic Earnings Per Share | 142.86%0.03 | -0.07 | 0.33 | - | -0.09 |
| Diluted Earnings Per Share | 142.86%0.03 | -0.07 | 0.33 | - | -0.09 |